Custom Inter-Flex 3D plate versus standard titanium plate for fixing mandibular (jaw) fractures

Evaluation of the Efficacy of Custom-Made Inter-flex Three-Dimensional Plate in Treatment of Mandibular Fracture A Randomized Controlled Clinical Trial

Not applicable Interventional Suez Canal University · NCT07263893

This trial will test whether a custom Inter-Flex 3D plate works better than ready-made titanium plates to repair recent, uninfected jaw fractures in adults.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment20 (estimated)
Ages18 Years to 50 Years
SexAll
SponsorSuez Canal University Academic / other
Locations1 site (Cairo)
Trial IDNCT07263893 on ClinicalTrials.gov

What this trial studies

This randomized interventional trial will treat 20 mandibular fracture sites divided equally into two groups: one fixed with a custom-made Inter-Flex three-dimensional plate and the other with ready-made titanium plates. Surgical planning for the custom plates uses digital modeling to produce a patient-specific fit, and outcomes include operative time, postoperative infection, occlusion, stability of the mandibular border, mouth opening, and radiographic healing. Follow-up visits occur immediately after surgery and at approximately 3 and 6 months to document clinical and radiographic outcomes. The trial is conducted at Mataria Teaching Hospital under Suez Canal University with standard open reduction and internal fixation techniques for all participants.

Who should consider this trial

Good fit: Adults with recent, uninfected, minimally displaced mandibular fractures that require open reduction and internal fixation and who are medically fit (ASA-1) are ideal candidates.

Not a fit: Patients with comminuted or infected fractures, osteoporosis, completely edentulous jaws, young children, or significant medical comorbidities are excluded and unlikely to benefit from this comparison.

Why it matters

Potential benefit: If successful, custom Inter-Flex 3D plates could shorten operative time and improve anatomical and functional restoration, potentially reducing mal-union and infection risk.

How similar studies have performed: Previous small series and biomechanical studies of patient-specific and 3D-designed mandibular plates have shown promising fit and functional results, but randomized evidence directly comparing them to standard plates is limited.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients who are suffering from recent, uninfected, and minimally displaced or unfavorable mandibular fractures
2. Adult patients with no gender predilection that agreed to present for follow-up visits for minimum postoperative period of immediate,3 months,6 months.
3. A fracture that demands open reduction and internal fixation
4. Patients under ASA-1 category

Exclusion Criteria:

1. Comminuted, infected mandibular fracture.
2. Pediatric patients below 4 years old and geriatric patients with completely edentulous mouth.
3. Patient with osteoporosis
4. Medical compromised patient (Poorly controlled DM or HTN, COPD, morbid obesity (BMI ≥40), Recent (\<3 months) MI, ongoing cardiac ischemia or severe valve dysfunction, severe reduction of ejection fraction, shock, sepsis, undergoing regularly scheduled dialysis, history (\>3 months)
5. Fractures in completely edentulous patients

Where this trial is running

Cairo

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Mandibular Fracture TreatmentINTER-FLEX 3D PLATEmandibular fracturesradiographic assesmenttime of surgeryhealing
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.